207 related articles for article (PubMed ID: 11002426)
21. Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses.
Levy L; Hill CS
Mol Cell Biol; 2005 Sep; 25(18):8108-25. PubMed ID: 16135802
[TBL] [Abstract][Full Text] [Related]
22. Growth factor-dependent activation of the Ras-Raf-MEK-MAPK pathway in the human pancreatic carcinoma cell line PANC-1 carrying activated K-ras: implications for cell proliferation and cell migration.
Giehl K; Skripczynski B; Mansard A; Menke A; Gierschik P
Oncogene; 2000 Jun; 19(25):2930-42. PubMed ID: 10871844
[TBL] [Abstract][Full Text] [Related]
23. Effects of inhibitors of signal transduction pathways on transforming growth factor beta1 and osteogenic protein-1-induced insulinlike growth factor binding protein-3 expression in human bone cells.
Srinivasan N; Baylink DJ; Sampath K; Mohan S
J Cell Physiol; 1997 Oct; 173(1):28-35. PubMed ID: 9326446
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of the tumor suppressor gene Smad4/DPC4 induces p21waf1 expression and growth inhibition in human carcinoma cells.
Hunt KK; Fleming JB; Abramian A; Zhang L; Evans DB; Chiao PJ
Cancer Res; 1998 Dec; 58(24):5656-61. PubMed ID: 9865717
[TBL] [Abstract][Full Text] [Related]
25. Antiestrogens induce growth inhibition by sequential activation of p38 mitogen-activated protein kinase and transforming growth factor-beta pathways in human breast cancer cells.
Buck MB; Pfizenmaier K; Knabbe C
Mol Endocrinol; 2004 Jul; 18(7):1643-57. PubMed ID: 15056732
[TBL] [Abstract][Full Text] [Related]
26. Transforming growth factor beta 1 induces proliferation in colon carcinoma cells by Ras-dependent, smad-independent down-regulation of p21cip1.
Yan Z; Kim GY; Deng X; Friedman E
J Biol Chem; 2002 Mar; 277(12):9870-9. PubMed ID: 11784716
[TBL] [Abstract][Full Text] [Related]
27. Cell-cycle-dependent expression of transforming growth factor beta type I receptor correlates with differential proliferative effects of TGFbeta1 in articular chondrocytes.
Boumediene K; Félisaz N; Pujol JP
Exp Cell Res; 1998 Aug; 243(1):173-84. PubMed ID: 9716461
[TBL] [Abstract][Full Text] [Related]
28. DPC4/SMAD4 mediated tumor suppression of colon carcinoma cells is associated with reduced urokinase expression.
Schwarte-Waldhoff I; Klein S; Blass-Kampmann S; Hintelmann A; Eilert C; Dreschers S; Kalthoff H; Hahn SA; Schmiegel W
Oncogene; 1999 May; 18(20):3152-8. PubMed ID: 10340387
[TBL] [Abstract][Full Text] [Related]
29. Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation.
Ellenrieder V; Hendler SF; Boeck W; Seufferlein T; Menke A; Ruhland C; Adler G; Gress TM
Cancer Res; 2001 May; 61(10):4222-8. PubMed ID: 11358848
[TBL] [Abstract][Full Text] [Related]
30. Growth of the pancreatic cancer cell line PANC-1 is inhibited by protein phosphatase 2A inhibitors through overactivation of the c-Jun N-terminal kinase pathway.
Li W; Chen Z; Gong FR; Zong Y; Chen K; Li DM; Yin H; Duan WM; Miao Y; Tao M; Han X; Xu ZK
Eur J Cancer; 2011 Nov; 47(17):2654-64. PubMed ID: 21958460
[TBL] [Abstract][Full Text] [Related]
31. TGFbeta1 signaling via alphaVbeta6 integrin.
Kracklauer MP; Schmidt C; Sclabas GM
Mol Cancer; 2003 Aug; 2():28. PubMed ID: 12935295
[TBL] [Abstract][Full Text] [Related]
32. Decreased sensitivity to 1-O-octadecyl-2-O-methyl-glycerophosphocholine in MCF-7 cells adapted for serum-free growth correlates with constitutive association of Raf-1 with cellular membranes.
Samadder P; Arthur G
Cancer Res; 1999 Oct; 59(19):4808-15. PubMed ID: 10519389
[TBL] [Abstract][Full Text] [Related]
33. Negative control of TRAIL-R1 signaling by transforming growth factor β1 in pancreatic tumor cells involves Smad-dependent down regulation of TRAIL-R1.
Radke DI; Ungefroren H; Helm O; Voigt S; Alp G; Braun H; Hübner S; Dilchert J; Sebens S; Adam D; Kalthoff H; Trauzold A
Cell Signal; 2016 Nov; 28(11):1652-62. PubMed ID: 27492861
[TBL] [Abstract][Full Text] [Related]
34. RAS/ERK modulates TGFbeta-regulated PTEN expression in human pancreatic adenocarcinoma cells.
Chow JY; Quach KT; Cabrera BL; Cabral JA; Beck SE; Carethers JM
Carcinogenesis; 2007 Nov; 28(11):2321-7. PubMed ID: 17638924
[TBL] [Abstract][Full Text] [Related]
35. Steps in integrin beta1-chain glycosylation mediated by TGFbeta1 signaling through Ras.
Bellis SL; Newman E; Friedman EA
J Cell Physiol; 1999 Oct; 181(1):33-44. PubMed ID: 10457351
[TBL] [Abstract][Full Text] [Related]
36. The Smad family and its role in pancreatic cancer.
Singh P; Wig JD; Srinivasan R
Indian J Cancer; 2011; 48(3):351-60. PubMed ID: 21921337
[TBL] [Abstract][Full Text] [Related]
37. Lactoferrin induces growth arrest and nuclear accumulation of Smad-2 in HeLa cells.
Zemann N; Klein P; Wetzel E; Huettinger F; Huettinger M
Biochimie; 2010 Jul; 92(7):880-4. PubMed ID: 20347004
[TBL] [Abstract][Full Text] [Related]
38. Anomalies of the TGF-beta postreceptor signaling pathway in ovarian cancer cell lines.
Hu W; Wu W; Nash MA; Freedman RS; Kavanagh JJ; Verschraegen CF
Anticancer Res; 2000; 20(2A):729-33. PubMed ID: 10810347
[TBL] [Abstract][Full Text] [Related]
39. PKCalpha mediates TGFbeta-induced growth inhibition of human keratinocytes via phosphorylation of S100C/A11.
Sakaguchi M; Miyazaki M; Sonegawa H; Kashiwagi M; Ohba M; Kuroki T; Namba M; Huh NH
J Cell Biol; 2004 Mar; 164(7):979-84. PubMed ID: 15051732
[TBL] [Abstract][Full Text] [Related]
40. sst2 Somatostatin receptor inhibits cell proliferation through Ras-, Rap1-, and B-Raf-dependent ERK2 activation.
Lahlou H; Saint-Laurent N; Estève JP; Eychène A; Pradayrol L; Pyronnet S; Susini C
J Biol Chem; 2003 Oct; 278(41):39356-71. PubMed ID: 12878607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
